Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 311
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
Nova Mentis Autism Clinical Study Approved by Institutional Review Board
The Effects of Antidepressant Discontinuation on MDMA-Assisted Psychotherapy
Should You Listen to Music During Psychedelic Treatments? How Sounds Impact...
Interview With Christi Myers
Interview With Ronan Levy
Will the Biden Administration Embrace Federal Psychedelic Reform?
Center for Psychedelic Medicine Established at NYU Langone Health
So, You Want to Take Ibogaine: Here’s What You Need to...
Red Light Holland Announces Closing of $11.6 Million Bought Deal Financing
Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences
Load more